PubMed ReviewObesity pharmacotherapy evidence2026 Glucagon-like receptor agonists and next-generation incretin-based medications Current review for incretin-based obesity medications and cardiometabolic effects
The Wegovy GLP-1 weight-loss pill has been approved in the UK, making it the first oral GLP-1 to be given the go-ahead in Europe
Prior Medication History: VA clinical guidelines require that you try and fail, or have a medical contraindication to, first-line generic diabetes medications (such as metformin) or other specific formulary alternatives before stepping up to a GLP-1
Experts previously warned of a sharp increase in services for women seeking menopausal relief, with concerns about their reliability and potential bias
They include being on the starter dose of 2.5 mg, needing a higher dose, other underlying medical reasons or hormonal imbalances, not eating in a calorie deficit, not getting enough protein and dietary fiber, or not working out